$55.4 Million is the total value of Healthcare Value Capital, LLC's 22 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 63.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GSK | Sell | GLAXOSMITHKLINE PLCsponsored adr | $4,268,000 | -11.1% | 100,000 | -16.7% | 7.71% | -14.4% |
| GILD | Sell | GILEAD SCIENCES INCcall | $3,169,000 | -68.7% | 50,000 | -66.7% | 5.72% | -69.9% |
| NVLNF | Sell | NOVELION THERAPEUTICS INC | $1,015,000 | -27.7% | 1,400,000 | -22.2% | 1.83% | -30.4% |
| GNLN | Sell | GREENLANE HLDGS INCcl a | $678,000 | -71.7% | 200,000 | -20.0% | 1.22% | -72.8% |
| CRON | Exit | CRONOS GROUP INCput | $0 | – | -50,000 | -100.0% | -1.50% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCput | $0 | – | -6,000 | -100.0% | -1.94% | – |
| PFE | Exit | PFIZER INC | $0 | – | -50,000 | -100.0% | -4.06% | – |
| CVS | Exit | CVS HEALTH CORPcall | $0 | – | -50,000 | -100.0% | -5.11% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INCput | $0 | – | -25,000 | -100.0% | -5.35% | – |
| JNJ | Exit | JOHNSON & JOHNSONcall | $0 | – | -25,000 | -100.0% | -6.53% | – |
| ABBV | Exit | ABBVIE INCcall | $0 | – | -50,000 | -100.0% | -6.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.